News & Publications
Find our latest news and analysis here. From the daily Newsstand to the Quarterly Journal, we cover the full breadth of intellectual property law.
Written April 1, 2019
Retractable Technologies, Inc. (RTI) and BD compete in the US safety syringe market; BD made several false claims in its marketing materials, including claims that it offered “the world’s sharpest needle” and that its syringes wasted less medicine per use. RTI sought disgorgement of profits which the district court denied because the relevant profits were subsumed by a trebled antitrust damages award RTI also received.
Although several key factors weighed in favor of disgorgement—particularly BD’s deceptive intentions and the public interest in making false advertising unprofitable—RTI failed to demonstrate that it lost business to BD, the court said.
Highlight your brand at a premier intellectual property law event, webinar, podcast, or in one of our publications.
For rates, availability, or additional details, click here or contact:
American Intellectual Property Law Association (AIPLA)